Impact of a Multiplex Polymerase Chain Reaction Assay on the Clinical Management of Adults Undergoing a Lumbar Puncture for Suspected Community-Onset Central Nervous System Infections
Matthew A. Moffa,
Derek N. Bremmer,
Dustin Carr,
Carley Buchanan,
Nathan R. Shively,
Rawiya Elrufay,
Thomas L. Walsh
Affiliations
Matthew A. Moffa
Division of Infectious Diseases, Allegheny General Hospital, Allegheny Health Network, 320 East North Avenue 4th Floor East Wing, Suite 406, Pittsburgh, PA 15212, USA
Derek N. Bremmer
Department of Pharmacy, Allegheny General Hospital, Allegheny Health Network, 320 East North Avenue 4th Floor East Wing, Suite 406, Pittsburgh, PA 15212, USA
Dustin Carr
Department of Pharmacy, Allegheny General Hospital, Allegheny Health Network, 320 East North Avenue 4th Floor East Wing, Suite 406, Pittsburgh, PA 15212, USA
Carley Buchanan
Department of Pharmacy, West Penn Hospital, Allegheny Health Network, 4800 Friendship Ave, Pittsburgh, PA 15224, USA
Nathan R. Shively
Division of Infectious Diseases, Allegheny General Hospital, Allegheny Health Network, 320 East North Avenue 4th Floor East Wing, Suite 406, Pittsburgh, PA 15212, USA
Rawiya Elrufay
Division of Infectious Diseases, Allegheny General Hospital, Allegheny Health Network, 320 East North Avenue 4th Floor East Wing, Suite 406, Pittsburgh, PA 15212, USA
Thomas L. Walsh
Division of Infectious Diseases, Allegheny General Hospital, Allegheny Health Network, 320 East North Avenue 4th Floor East Wing, Suite 406, Pittsburgh, PA 15212, USA
Patients admitted from the community with a suspected central nervous system (CNS) infection require prompt diagnostic evaluation and correct antimicrobial treatment. A retrospective, multicenter, pre/post intervention study was performed to evaluate the impact that the BioFire® FilmArray® meningitis/encephalitis (ME) panel run in-house had on the clinical management of adult patients admitted from the community with a lumbar puncture (LP) performed for a suspected CNS infection. The primary outcome was the effect that this intervention had on herpes simplex virus (HSV) polymerase chain reaction (PCR) turnaround time (TAT). Secondary outcomes included the effect that this intervention had on antiviral days of therapy (DOT), total antimicrobial DOT, and hospital length of stay (LOS). A total of 81 and 79 patients were included in the pre-intervention and post-intervention cohorts, respectively. The median HSV PCR TAT was significantly longer in the pre-intervention group (85 vs. 4.1 h, p p p p = 0.02). Implementing the ME panel in-house for adults undergoing an LP for a suspected community-onset CNS infection significantly reduced the HSV PCR TAT, antiviral DOT, total antimicrobial DOT, and hospital LOS.